| Date Filed | Type | Description |
| 07/27/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised 1,667 options to buy
@ $5.95, valued at
$9.9k
|
|
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| UECKER DARRIN (Chief Technology Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.08, valued at
$1.4M
|
|
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised 65,000 options to buy
@ $2.14, valued at
$139.1k
Exercised 65,467 options to buy
@ $2.14, valued at
$140.1k
Exercised 1,666 options to buy
@ $5.95, valued at
$9.9k
|
|
| 07/06/2023 |
4/A
| UECKER DARRIN (Chief Technology Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 7,365 warrants
@ $2.05, valued at
$15.1k
|
|
| 07/06/2023 |
4/A
| Levinson Mitchell E. (Chief Strategy Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 10,935 warrants
@ $2.05, valued at
$22.4k
Exercised (in-or-at-the-money) 814 warrants
@ $2.05, valued at
$1.7k
Exercised (in-or-at-the-money) 143 warrants
@ $2.05, valued at
$293.2 |
|
| 07/06/2023 |
4/A
| Zanganeh Mahkam (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 86,668 warrants
@ $2.05, valued at
$177.7k
|
|
| 06/16/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 5,683,163 warrants
@ $2.05, valued at
$11.7M
Exercised (in-or-at-the-money) 81,025 warrants
@ $2.05, valued at
$166.1k
|
|
| 06/06/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
Granted 39,731 options to buy
@ $5.95, valued at
$236.4k
|
|
| 06/06/2023 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
|
|
| 06/06/2023 |
4
| Spray Shelley D (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
|
|
| 06/06/2023 |
4
| Zanganeh Mahkam (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
Granted 20,168 options to buy
@ $5.95, valued at
$120k
|
|
| 06/06/2023 |
4
| van den Broek Richard (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
Granted 28,487 options to buy
@ $5.95, valued at
$169.5k
|
|
| 05/10/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Bought 10,022,937 shares
@ $6.51, valued at
$65.2M
|
|
| 05/09/2023 |
4
| Levinson Mitchell E. (Chief Strategy Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 17,700 options to buy
@ $8.02, valued at
$142k
Granted 2,000 options to buy
@ $5.81, valued at
$11.6k
|
|
| 05/02/2023 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 500,000 options to buy
@ $6.44, valued at
$3.2M
|
|
| 05/02/2023 |
4
| UECKER DARRIN (Chief Technology Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 500,000 options to buy
@ $6.44, valued at
$3.2M
|
|
| 03/24/2023 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $6.41, valued at
$160.3k
|
|
| 03/24/2023 |
4
| Levinson Mitchell E. (Chief Strategy Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.92, valued at
$102.2k
|
|
| 10/11/2022 |
4
| Levinson Mitchell E. (Chief Strategy Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Bought 8,770 shares
@ $2.29, valued at
$20.1k
Bought 8,810 shares
@ $2.27, valued at
$20k
Bought 4,400 shares
@ $2.26, valued at
$9.9k
Bought 4,500 shares
@ $2.23, valued at
$10k
Bought 4,300 shares
@ $2.29, valued at
$9.8k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| Danahy Kevin Patrick (CEO) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 450,000 options to buy
@ $1.53, valued at
$688.5k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Levinson Mitchell E. (Chief Strategy Officer) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 10,935 shares
@ $0
Exercised (in-or-at-the-money) 814 shares
@ $0
Exercised (in-or-at-the-money) 143 shares
@ $0
Bought 10,935 warrants
@ $0
Bought 814 warrants
@ $0
Bought 143 warrants
@ $0 |
|
| 06/10/2022 |
4
| UECKER DARRIN (Director) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 7,365 shares
@ $0
Bought 7,365 warrants
@ $0 |
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| Danahy Kevin Patrick (Chief Commercial Office) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 300,000 options to buy
@ $6.41, valued at
$1.9M
|
|
| 03/22/2022 |
3
| Danahy Kevin Patrick (Chief Commercial Officer) has filed a Form 3 on Pulse Biosciences, Inc. |
|